Greenland Mines Ltd (GRML)

• Market cap: $35.5M
• 1 day: -3.93%
• 5 days: -2.33%
• 1 month: -30.24%
• 3 months: -37.39%
• 6 months: -26.82%
• Year to date: -8.29%
• 1 year: -85.35%
• 5 years: -97.04%
• 10 years: -97.04%
• Sector: Materials
• Industry: Other Precious Metals & Mining

About: Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Employees: 5